AtriCure, Inc.·4

Sep 7, 4:48 PM ET

Drachman David J 4

4 · AtriCure, Inc. · Filed Sep 7, 2012

Insider Transaction Report

Form 4
Period: 2012-09-05
Drachman David J
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2012-09-05$6.55/sh50,000$327,500334,983 total
  • Sale

    Common Stock

    2012-09-06$6.53/sh180,583$1,179,207154,400 total
  • Sale

    Common Stock

    2012-09-07$6.80/sh8,400$57,120146,000 total
Footnotes (3)
  • [F1]This transaction was executed in multiple trades at prices ranging from $6.50 to $7.03 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F2]This transaction was executed in multiple trades at prices ranging from $6.50 to $6.79 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]This transaction was executed in multiple trades at prices ranging from $6.79 to $6.84 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    rrd355520.xmlPrimary

    FORM 4